Establishing Mechanical Thrombectomy at a Limited-volume Stroke Center - Effects on Patient Morbidity and Mortality

Sponsor
Sorlandet Hospital HF (Other)
Overall Status
Recruiting
CT.gov ID
NCT04942041
Collaborator
South-Eastern Norway Regional Health Authority (Other), Helse Stavanger HF (Other), University of Stavanger (Other)
300
1
71
4.2

Study Details

Study Description

Brief Summary

The regional health authorities of South-East Norway has commissioned Sørlandet Hospital (SSHF), Norway to establish mechanical thrombectomy in large-vessel occlusion stroke. SSHF is a limited volume stroke center, and introduction of thrombectomy may impose quality challenges. Therefore the implementation will be guided by a simulation based quality assurance program. In this study, we will monitor timelines, technical and clinical outcomes, including adverse events.

Condition or Disease Intervention/Treatment Phase
  • Other: Simulation based quality program

Detailed Description

In acute stroke, two million neurons are lost per minute. Thrombectomy is the treatment of choice for large vessel occlusion stroke: Each minute saved from stroke onset to successful thrombectomy on average extends the healthy life of young patients by a week. Also, more patients may have a thrombectomy option with early treatment, as the time window for thrombectomy is limited.

In 2019, Sørlandet Hospital Kristiansand (SSK) established thrombectomy for stroke. This spared SSK patients from an over 300 km transport to the comprehensive thrombectomy center in Oslo. Avoiding delays due to long transports may lead to lower morbidity and mortality.

However, SSK is a non-university hospital with a limited patient volume, which may contribute to inferior results. To compensate for this, the implementation of thrombectomy at SSK is guided by a national quality program, which includes systematic skill training, simulation team training and continuous local guideline updates.

The primary objective of this observational study is to find out if implementation of thrombectomy at SSK, guided by the quality program, reduces patient morbidity and mortality.

Long transfer times from smaller hospitals to comprehensive thrombectomy centers pose a major problem for the global stroke community. Thus, our results could be generalizable.

Main aim:

• To determine potential changes in patient morbidity and mortality after introduction of thrombectomy at SSK

Secondary aims:
  • To describe associated time periods based on stroke onset, hospital arrival, thrombectomy start, end of procedure

  • To document technical outcomes of mechanical thrombectomies performed at SSK, i.e. degree of reperfusion after thrombectomy

  • To document complication rates during mechanical thrombectomies performed at SSK

  • To describe the implementation of the quality program at SSK

  • To document performance of simulator skill training over time

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Case-Control
Time Perspective:
Other
Official Title:
Establishing Mechanical Thrombectomy at a Limited-volume Stroke Center - Effects on Patient Morbidity and Mortality.
Actual Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Dec 1, 2026
Anticipated Study Completion Date :
Dec 1, 2026

Arms and Interventions

Arm Intervention/Treatment
local thrombectomy

Large vessel occlusion stroke patients that received thrombectomy at the local center

Other: Simulation based quality program
Stroke team simulation. Virtual reality task training simulation.

distant thrombectomy

Large vessel occlusion stroke patients that received thrombectomy at the distant center

Outcome Measures

Primary Outcome Measures

  1. Mortality [3 months]

  2. Morbidity [3 months]

    Modified Rankin Scale. Minimum value 0 meaning perfect health without symptoms. Maximum value 6 meaning death.

  3. Symptomatic intracranial hemorrhage [Within 24 hours of treatment]

    Any intracranial hemorrhage with neurologic deterioration leading to an increase in NIHSS score ⬎4 or leading to death

Secondary Outcome Measures

  1. Time frames [Up to 24 hours]

    Time periods based on stroke onset, hospital arrival, thrombectomy start, and end of procedure

  2. Technical outcome [Up to 24 hours]

    Reperfusion graded by modified Thrombolysis in Cerebral Infarction scale. Minimum value 0 meaning no reperfusion. Maximum value 3 meaning complete antegrade reperfusion of the previously occluded target artery ischemic territory, with absence of visualized occlusion in all distal branches

  3. Simulation skills [Up to 5 years]

    Performance of simulator skills before and after a training period. The simulator software records time consumption (seconds), handling errors (number of turns, centimeter movement), fluoroscopy time (seconds), and radiation exposure (Grey per cm2)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients

  • Large vessel occlusion stroke

Exclusion Criteria:
  • Intracranial hemorrhage, tumor, aneurism or vascular malformation i the stroke area

  • More than 24 hours after stroke onset

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sørlandet Hospital Health Trust Kristiansand Agder Norway 4604

Sponsors and Collaborators

  • Sorlandet Hospital HF
  • South-Eastern Norway Regional Health Authority
  • Helse Stavanger HF
  • University of Stavanger

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sorlandet Hospital HF
ClinicalTrials.gov Identifier:
NCT04942041
Other Study ID Numbers:
  • 66489 (REK)
First Posted:
Jun 28, 2021
Last Update Posted:
Nov 15, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sorlandet Hospital HF
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 15, 2021